Horizon Therapeutics Plc (HZNP)

26.51
0.10 0.38
NASDAQ : Health Technology
Prev Close 26.41
Open 26.52
Day Low/High 26.34 / 26.80
52 Wk Low/High 16.56 / 29.44
Volume 849.03K
Avg Volume 1.81M
Exchange NASDAQ
Shares Outstanding 186.45M
Market Cap 4.97B
EPS -0.50
P/E Ratio 68.38
Div & Yield N.A. (N.A)
Horizon Raises Bid for Specialty Pharma Company Depomed

Horizon Raises Bid for Specialty Pharma Company Depomed

The offer comes just three months after Depomed purchases the diabetes-related pain drug Nucynta from a subsidiary of Johnson & Johnson.

'Mad Money' Lightning Round: You Want Yahoo!

'Mad Money' Lightning Round: You Want Yahoo!

Cramer says to stay away from Alibaba but go for Yahoo!

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Cramer says you've got to listen to the commentary on earnings from Apple tomorrow, not to mention what's up with Microsoft and falling PC sales.

Use Options For a Chance To Buy HZNP at a 44% Discount

Use Options For a Chance To Buy HZNP at a 44% Discount

Looking back to 96 days ago, Horizon Pharma plc priced a 15,350,000 share secondary stock offering at $28.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 35.6% above the offering price.

Horizon Pharma (HZNP) Stock Gains on Strong Guidance

Horizon Pharma (HZNP) Stock Gains on Strong Guidance

Horizon Pharma (HZNP) shares are rising after the company provided upside second quarter and full year revenue guidance.

Strong Upward Pre-Market Activity For Horizon Pharma (HZNP)

Strong Upward Pre-Market Activity For Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market leader candidate

Will Horizon Pharma (HZNP) Stock be Hurt by DepoMed's Poison Pill?

Will Horizon Pharma (HZNP) Stock be Hurt by DepoMed's Poison Pill?

Horizon Pharma (HZNP) shares are showing volatility after the object of its takeover interest, DepoMed (DEPO), adopted a poison pill to dissuade any further unsolicited offers.

Horizon Pharma (HZNP) Hits New Lifetime High

Horizon Pharma (HZNP) Hits New Lifetime High

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Market Wrap: Stocks Make Quick Recovery

Second-half rebound erases losses.

Stocks Close Higher on Hopes Greece Reaches Deal Soon

Stocks Close Higher on Hopes Greece Reaches Deal Soon

After a volatile session, stocks close positive as investors cling to hopes that Greece puts forth a suitable debt proposal, expected Wednesday.

Stocks Turn Positive on Hopes for Greece Reforms

Stocks Turn Positive on Hopes for Greece Reforms

U.S. stocks turn positive in late trading on Tuesday, with reports saying Greece has proposed a solution to keep the country afloat for July.

Horizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bid

Horizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bid

Horizon Pharma (HZNP) shares are declining after rival DepoMed (DEPO) rejected the company's $3 billion merger bid today.

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Under proposed transaction's terms, Horizon Pharma would acquire all outstanding shares of Depomed for $29.25 each in an all-stock transaction, a 42% premium to its closing price on Monday.

Stocks Fall as Greek Resolution Deemed Urgent

Stocks Fall as Greek Resolution Deemed Urgent

U.S. stocks extend losses after reports suggest European leaders could push Greece out of the eurozone if the debt-laden nation doesn't come up with a viable reform proposal.

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Horizon Pharma (HZNP) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market mover with heavy volume candidate

Stock Futures Slightly Higher Ahead of Greece Summit

Stock Futures Slightly Higher Ahead of Greece Summit

U.S. stock futures rise on hopes European leaders will provide short-term liquidity to Greek banks.

Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed

Like other specialty pharmaceutical makers headquartered in tax-friendly countries, Horizon is buying growth.

10 Best Biotech Stocks in the NASDAQ

10 Best Biotech Stocks in the NASDAQ

The biotech sector has been one of the fastest growing sectors through June 30, 2015. Here are the 10 best biotech stocks this year.

New Lifetime High Reached By Horizon Pharma (HZNP)

New Lifetime High Reached By Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Horizon Pharma (HZNP) Marked As A Barbarian At The Gate

Horizon Pharma (HZNP) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Horizon Pharma (HZNP) Flagging After Hours

Horizon Pharma (HZNP) Flagging After Hours

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a post-market laggard candidate

Jim Cramer -- Micron, Other PC-Tied Chip Stocks Continue to Struggle

Jim Cramer -- Micron, Other PC-Tied Chip Stocks Continue to Struggle

TheStreet's Jim Cramer likes Horizon Pharma for more upside and says chip companies are smart to diversify their business streams.

New Lifetime High For Horizon Pharma (HZNP)

New Lifetime High For Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Jim Cramer's Top Takeaways: Verizon, Yahoo!, Horizon Pharma, Apple, Salesforce.com, Dun & Bradstreet

Jim Cramer's Top Takeaways: Verizon, Yahoo!, Horizon Pharma, Apple, Salesforce.com, Dun & Bradstreet

Why shouldn't Verizon buy Yahoo!? Cramer asks. He also likes the technical indicators for Apple and Salesforce.com.

Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers

Jim Cramer's 'Mad Money' Recap: Here Are My Dream Mergers

Google buying Twitter? Verizon buying Yahoo!? Johnson & Johnson buying Bristol-Myers? Why not? Cramer asks.

Anything Goes in This Merger Era

If anything, I am being too small-minded when it comes to mergers.

New Lifetime High Reached By Horizon Pharma (HZNP)

New Lifetime High Reached By Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Jim Cramer's Top Takeaways: Actavis, Rite Aid, Receptos

Jim Cramer's Top Takeaways: Actavis, Rite Aid, Receptos

Cramer is impressed by Rite Aid, even though it is expensive, and Receptos, which he says is the best early-stage biotech.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching earnings from Sears, Lululemon and Cisco, among others, next week.

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.

TheStreet Quant Rating: C+ (Hold)